Business Description
Verici Dx PLC
ISIN : GB00BM8HZD43
Share Class Description:
VRCDF: Ordinary SharesDescription
Verici Dx PLC is an immuno-diagnostics development company. The company is focused on developing diagnostics technologies that will help understand the outcomes of an organ transplant surgery. There are two products for clinical validation and commercialization: Clarava, which is a pre-transplant prognosis for the risk of early acute rejection; and Tuteva, a post-transplant diagnostic focused upon acute cellular rejection including sub-clinical rejection not being diagnosed through the current standard of care of rising serum creatine levels. The business of the Group comprises a single activity, which of the development of prognostic and diagnostic tests for kidney transplant patients.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 15.32 | |||||
| Equity-to-Asset | 0.82 | |||||
| Debt-to-Equity | 0.05 | |||||
| Debt-to-EBITDA | -0.11 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | -8.65 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Book Growth Rate | -45.1 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-1 Month Momentum % | -66.67 | |||||
| 6-1 Month Momentum % | -66.67 | |||||
| 12-1 Month Momentum % | -65.12 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.54 | |||||
| Quick Ratio | 4.54 | |||||
| Cash Ratio | 3.56 | |||||
| Days Sales Outstanding | 71.17 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -6.3 | |||||
| Shareholder Yield % | -98.98 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -114.32 | |||||
| Net Margin % | -111.29 | |||||
| FCF Margin % | -133.65 | |||||
| ROE % | -71.77 | |||||
| ROA % | -49.91 | |||||
| ROIC % | -94.05 | |||||
| ROC (Joel Greenblatt) % | -343.12 | |||||
| ROCE % | -67.61 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 1.54 | |||||
| PB Ratio | 0.82 | |||||
| Price-to-Tangible-Book | 1 | |||||
| EV-to-EBIT | -0.33 | |||||
| EV-to-EBITDA | -0.39 | |||||
| EV-to-Revenue | 0.36 | |||||
| EV-to-FCF | -0.27 | |||||
| Price-to-Net-Current-Asset-Value | 1.5 | |||||
| Price-to-Net-Cash | 1.5 | |||||
| Earnings Yield (Greenblatt) % | -303.03 | |||||
| FCF Yield % | -71.65 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:VRCDF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Verici Dx PLC Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 4.333 | ||
| EPS (TTM) ($) | -0.026 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 77.31 | ||
| 14-Day RSI | - | ||
| 14-Day ATR ($) | 0.000356 | ||
| 20-Day SMA ($) | 0.03 | ||
| 12-1 Month Momentum % | -65.12 | ||
| 52-Week Range ($) | 0.03 - 0.12 | ||
| Shares Outstanding (Mil) | 242.54 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Verici Dx PLC Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Verici Dx PLC Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Verici Dx PLC Frequently Asked Questions
What is Verici Dx PLC(VRCDF)'s stock price today?
The current price of VRCDF is $0.03. The 52 week high of VRCDF is $0.12 and 52 week low is $0.03.
When is next earnings date of Verici Dx PLC(VRCDF)?
The next earnings date of Verici Dx PLC(VRCDF) is 2025-05-30 Est..
Does Verici Dx PLC(VRCDF) pay dividends? If so, how much?
Verici Dx PLC(VRCDF) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers